Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.72 USD
−7.99 M USD
6.00 M USD
15.42 M
About Coya Therapeutics, Inc.
Sector
Industry
CEO
Arun Swaminathan
Website
Headquarters
Houston
Founded
2020
FIGI
BBG00Z4HBCB9
Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of COYA is 6.50 USD — it hasn't changed in the past 24 hours. Watch Coya Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Coya Therapeutics, Inc. stocks are traded under the ticker COYA.
COYA stock has risen by 1.40% compared to the previous week, the month change is a −34.01% fall, over the last year Coya Therapeutics, Inc. has showed a 26.80% increase.
We've gathered analysts' opinions on Coya Therapeutics, Inc. future price: according to them, COYA price has a max estimate of 18.00 USD and a min estimate of 14.00 USD. Watch COYA chart and read a more detailed Coya Therapeutics, Inc. stock forecast: see what analysts think of Coya Therapeutics, Inc. and suggest that you do with its stocks.
COYA reached its all-time high on Mar 18, 2024 with the price of 10.69 USD, and its all-time low was 3.21 USD and was reached on Aug 18, 2023. View more price dynamics on COYA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
COYA stock is 5.16% volatile and has beta coefficient of 1.62. Track Coya Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Coya Therapeutics, Inc. there?
Yes, you can track Coya Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Coya Therapeutics, Inc. is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
COYA earnings for the last quarter are −0.26 USD per share, whereas the estimation was −0.36 USD resulting in a 28.22% surprise. The estimated earnings for the next quarter are −0.30 USD per share. See more details about Coya Therapeutics, Inc. earnings.
Coya Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of 1.88 M USD. In the next quarter, revenue is expected to reach 100.00 K USD.
COYA net income for the last quarter is −4.02 M USD, while the quarter before that showed −2.89 M USD of net income which accounts for −39.07% change. Track more Coya Therapeutics, Inc. financial stats to get the full picture.
No, COYA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 26, 2024, the company has 8.00 employees. See our rating of the largest employees — is Coya Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Coya Therapeutics, Inc. EBITDA is −11.11 M USD, and current EBITDA margin is −122.17%. See more stats in Coya Therapeutics, Inc. financial statements.
Like other stocks, COYA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Coya Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Coya Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Coya Therapeutics, Inc. stock shows the buy signal. See more of Coya Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.